6533b85efe1ef96bd12c05ad
RESEARCH PRODUCT
PORCNmutations in focal dermal hypoplasia: coping with lethality
Kaatje HeineltJuliane StrienAnnalisa PatriziMaría Del Carmen BoenteKarl-heinz GrzeschikYasemin AlanayNicolas ChassaingBen C.j. HamelIngo LohrischMarie Eleanore O. NicolasG. Eda UtineIan O. EllisCarlo MarcelisJeffrey A. AschermanKatrina PrescottBart LoeysArne KönigMauro ParadisiChristina Raissa I. FranciscoWolfgang KastrupFrank OeffnerPatricia Silvia Della GiovannaPaul J. BenkeDorothea BornholdtMaria PiccioneYasmin MehraeinCristina HasAndreas R. JaneckeIneke Van Der BurgtBettina PragerDana PagliariniHildegunde Piza-katzerMarc S. ZellerRudolf Happlesubject
GeneticsMutationGenetic counselingNonsense mutationBiologymedicine.disease_causemedicine.diseaseFocal dermal hypoplasiaPORCNGeneticsmedicineMissense mutationSkewed X-inactivationGenetics (clinical)Loss functiondescription
The X-linked dominant trait focal dermal hypoplasia (FDH, Goltz syndrome) is a developmental defect with focal distribution of affected tissues due to a block of Wnt signal transmission from cells carrying a detrimental PORCN mutation on an active X-chromosome. Molecular characterization of 24 unrelated patients from different ethnic backgrounds revealed 23 different mutations of the PORCN gene in Xp11.23. Three were microdeletions eliminating PORCN and encompassing neighboring genes such as EBP, the gene associated with Conradi-Hunermann-Happle syndrome (CDPX2). 12/24 patients carried nonsense mutations resulting in loss of function. In one case a canonical splice acceptor site was mutated, and 8 missense mutations exchanged highly conserved amino acids. FDH patients overcome the consequences of potentially lethal X-chromosomal mutations by extreme skewing of X-chromosome inactivation in females, enabling transmission of the trait in families, or by postzygotic mosaicism both in male and female individuals. Molecular characterization of the PORCN mutations in cases diagnosed as Goltz syndrome is particularly relevant for genetic counseling of patients and their families since no functional diagnostic test is available and carriers of the mutation might otherwise be overlooked due to considerable phenotypic variability associated with the mosaic status.
year | journal | country | edition | language |
---|---|---|---|---|
2009-03-23 | Human Mutation |